在癌症中对艺术素及其衍生物进行图书法测量和可视化分析
Jiaming Feng1, Yuqing He1, Ting Bai1
1Department of Anatomy, School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People's Republic of China.
Drug design, development and therapy
|July 7, 2025
概括
这项文献计量研究揭示了阿尔特米西宁及其衍生物在癌症治疗中的研究趋势日益增长. 中国在出版物方面处于领先地位,主要研究领域包括抗癌活性和细胞循环停止.
科学领域:
- 药理学和瘤学 药理学和瘤学
- 传统中国医学 (TCM) 研究研究
- 圣经计量和科学计量分析
背景情况:
- 来自 * Artemisia annua * 的艺术素,在癌症治疗中显示出显著的治疗潜力.
- 尽管它充满希望,但系统的科学测量研究缺乏关于素在癌症研究中的作用.
- 这项研究解决了对素及其衍生物用于癌症治疗的研究趋势进行全面分析的需要.
研究的目的:
- 提供关于素及其衍生物在癌症中的研究的全面摘要.
- 想象当前的研究进展,并确定该领域的关键热点.
- 概述未来发展的尖端趋势,以素为基础的癌症治疗.
主要方法:
- 从1990年到2023年对927篇出版物的图书统计分析,来源于科学网络核心集合 (WOSCC).
- 使用CiteSpace,VOSviewer和微软Excel进行数据分析.
- 分析了出版趋势,国家贡献,共同引用的参考文献和关键词.
主要成果:
- 观察到全球关于美素和瘤治疗的出版物稳步增加.
- 中国成为出版量领先的国家,具有显著的学术影响力.
- 关键的研究主题包括阿美西宁类药物,巴克斯介导的内在途径和感染的红细胞,以及癌症,体外,循环停止,抗癌活性和*Plasmodium falciparum*等关键词.
结论:
- 本研究提供了关于素及其衍生物在癌症中的研究趋势的全面概述.
- 这些发现为该领域的研究人员提供了宝贵的数据和见解.
- 它是对有兴趣探索基于美素的癌症治疗方法的研究人员的指南.
相关概念视频
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:49Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
01:21Cancer Survival Analysis
457
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
457
01:15Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K